We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Expected Revenues of Hologic Up in First Quarter of 2015

By MedImaging International staff writers
Posted on 27 Jan 2015
Hologic (Bedford, MA, USA), a global healthcare and diagnostics company, has announced that it expects total revenues for first fiscal quarter of 2015 to reach approximately USD 653 million—7% more than the year before.

The company provided the business updates in preparation for its participation in the 33rd Annual J.P. Morgan Healthcare Conference.

The estimated revenue increase is shared among all Hologic business segments: diagnostics (USD 304 million), breast health (USD 242 million), surgical gynecology (GYN) (USD 84 million), and skeletal health (USD 22 million). Hologic also announced that it had made a voluntary prepayment of USD 300 million of principal on a Term Loan B facility in December 2014.

The company produces a range of diagnostic imaging products and software including the Affirm breast biopsy guidance system, Aixplorer MultiWave ultrasound system, and MultiView image analysis software.

Steve MacMillan, Hologic's president and chief executive officer, stated, "This better-than-expected performance, combined with the voluntary prepayment of debt, provide further evidence of a turnaround that continues to build momentum.”

Related Links:

Hologic


MRI System
nanoScan MRI 3T/7T
Diagnostic Ultrasound System
DC-80A
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Digital X-Ray Detector Panel
Acuity G4

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.